Scilex Holding Company revenue breakdown overview

Scilex Holding Company revenue for the last year amounted to 69.38 M USD, the most of which — 56.59 M USD — came from its highest performing source at the moment, Non-Opioid Pain Management Products, the year earlier bringing 46.74 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Scilex Holding Company 56.59 M USD, and the year before that — 46.74 M USD.